Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Volitionrx Ltd (VNRX)

Volitionrx Ltd (VNRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Volitionrx Ltd 13215 BEE CAVE PARKWAY GALLERIA OAKS B SUITE 125 AUSTIN TX 78738 USA

P: 646-650-1351

Description:

Volition RX Ltd is a life sciences company engaged in developing a range of blood-based epigenetic cancer diagnostic tests. Its tests are designed to detect the nucleosome patterns that are specific to cancer in the blood, and identify some of the major nucleosome varieties that differ between cancer types. The Company's development activities are primarily centered in Belgium. Volition RX Ltd is based in Singapore.

Key Statistics

Overview:

Market Capitalization, $K 168,200
Shares Outstanding, K 52,893
Annual Sales, $ 10 K
Annual Net Income, $ -20,350 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -6,120 K
60-Month Beta 1.76
% of Insider Shareholders 15.40%
% of Institutional Shareholders 16.47%
Float, K 44,747
% Float 84.60%

Growth:

1-Year Return -3.05%
3-Year Return 83.82%
5-Year Return -6.19%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 16.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/12/21
Earnings Per Share ttm -0.44
EPS Growth vs. Prev Qtr -9.09%
EPS Growth vs. Prev Year 14.29%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

VNRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -4.94
Price/Earnings to Growth N/A
Return-on-Equity % -96.93%
Return-on-Assets % -69.31%
Profit Margin % -203,500.01
Net Margin % N/A
Debt/Equity 0.09
Price/Sales 12,816.38
Price/Cash Flow N/A
Price/Book 5.24
Book Value/Share 0.59
Interest Coverage -155.92
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar